estrogen replenishment therapy and combination estrogen/progestin hormonal replenishment therapy in healthy menopausal women, respectively; (ix) if we do not successfully manage any growth we experience, we may experience increased expenses without corresponding revenue increases; (x) we are dependent on single sources of supply for all of the products New Era Yankees 920 Washed At Navy/Cream
Women First HealthCare, Inc. (WFHC) Amends Promissory Note To Wyeth (WYE)Genzyme Corporation (GENZ) To Establish Research Facility In Europe; Employ 150 Staff Within Five Years
we offer; (xi) reduced consumer confidence could adversely affect sales by our Consumer Business Division; (xii) our third party suppliers and licensors may terminate their agreements with us earlier than we expect, and as a result we may be unable to continue to market and sell the related pharmaceutical products on an exclusive basis or at all; (xiii) if we overestimate demand for our products, we may be required to write off inventories and/or increase our reserves in future periods, (xiv) we have incurred significant debt obligations which will require us to make debt service payments in the future; and (xv) additional factors set forth in the company's Securities and Exchange Commission filings including its Annual Report on Form 10 K for the period ended December 31, 2002 and its Form 10 Q for the periods ended March 31, 2003, June 30, 2003 and September 30, 2003.
Women First HealthCare Inc. (Nasdaq: WFHC News) is a San Diego based specialty pharmaceutical company. Founded in 1996, its mission is to help midlife women make informed choices regarding their health care and to provide pharmaceutical products the company's primary emphasis and lifestyle products to meet their needs. Women First HealthCare is specifically targeted to women age 40+ and their clinicians.
Merck's Top Researcher Leaves; Joins HIV Vaccine Group FulltimeParadigm Therapeutics Limited Names Mark Carlton CEO
Source: Women First HealthCare Inc.
Commenting, Calesa said, "This team of experienced pharmaceutical executives has tremendous spirit and dedication. I believe their leadership and experience will help keep Women First HealthCare firmly on course to achieve our goals."
and our products face significant competition; (viii) our products may not achieve or maintain market acceptance for a variety of reasons, including as a result of recent research published by the National Cancer Institute and the National Institutes of Health concerning Nike Cap Snapback Price
SAN DIEGO (BUSINESS WIRE) Jan. 15, 2004 Women First HealthCare Inc. (Nasdaq: WFHC News) today announced that Edward F. Calesa has resumed his former roles of chief operating officer and president. This is in addition to his role as chairman, chief executive officer and co founder. The management team, who report directly to Calesa, will support him as an integrated group. The management team includes Randi Crawford, co founder and vice president, consumer business; Saundra Pelletier, vice president, pharmaceuticals; and Richard Vincent, chief financial officer. Calesa assumes the role and responsibilities of Michael Sember, former chief operating officer and president. Sember is leaving to pursue other interests.
Vion Pharmaceuticals (VION) Appoints CFO Johnson As PresidentMedImmune (MEDI) Announces Departure Of Chief Financial Officer
Schering Plough Corporation (SGP) Cutting Jobs In IrelandStrategic Diagnostics (SDIX) Announces Management Restructuring; Eliminated The Chief Operating Officer Position
This press release contains certain "forward looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. These statements are often, but not always, made through the use of words or phrases such as "believe," "will," "expect," "anticipate," "estimate," "intend," "plan" and "would." Such forward looking statements are subject to various risks, and Women First HealthCare Inc. cautions you that any forward looking information is not a guarantee of future performance. Women First HealthCare Inc. disclaims any intent or obligation to update these forward looking statements. Actual results could differ materially due to a number of factors, including (i) if we overestimate demand for our products we could be required to write off inventories and/or increase our reserves, and if we underestimate demand we might not be able to fulfill orders for our products; (ii) if our assumptions about our cash generation and usage are incorrect, we may be forced to withhold payment to suppliers, debt holders and others and to file for bankruptcy protection, which could diminish completely the value of an investment in our common stock; (iii) we may not maintain compliance with the new covenant levels established with respect to the senior secured notes; (iv) we have incurred significant losses since we were founded in November 1996, and if midlife women do not use, and their clinicians do not recommend, the products we offer, we will experience losses in the future; (v) there is a limited market awareness of our company and the products and services we offer; (vi) we may not be able to identify appropriate acquisition, licensing or co promotion candidates in the future or to take advantage of the opportunities we identify; (vii) we Adidas Hat Tan
1 Announces Management Change Edward F Calesa Has Resumed His Former Roles Ny Hat Of Chief Operating Offi
Ny Cap Women
Nike Hat Beanie
New Era Yankees Cap
Colorado Rockies Hats New Era
Versace Belts For Sale
Atlanta Braves Caps New Era
New York Knicks Cap
Ny Yankees Hat Womens
Nike Hat Metal Swoosh
Louis Vuitton Belt Buckle Repair
Hermes Belt Price For Women
Adidas Hat Navy
Gucci Belt Green Snake
Gucci Belt For Men 2018
Nike Cap Black